Your browser doesn't support javascript.
loading
Skin barrier, phenotypic and genotypic characterisation of autosomal recessive ichthyosis in TGM1-deficient Jack Russell Terriers and response to topical ceramide.
Mauldin, Elizabeth; Bradley, Charles; Casal, Margret; Meyer, Jason; Crumrine, Debra; Kiener, Sarah; Leeb, Tosso; Elias, Peter M.
Afiliação
  • Mauldin E; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Bradley C; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Casal M; Section of Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Meyer J; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Crumrine D; Veterans Affairs Medical Center, University of California, San Francisco, California, USA.
  • Kiener S; Institute of Genetics, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Leeb T; Institute of Genetics, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
  • Elias PM; Veterans Affairs Medical Center, University of California, San Francisco, California, USA.
Vet Dermatol ; 2024 Aug 08.
Article em En | MEDLINE | ID: mdl-39118209
ABSTRACT

BACKGROUND:

Autosomal recessive ichthyosis leads to structural or biochemical changes that impair skin barrier function. HYPOTHESIS/

OBJECTIVES:

To assess (1) the phenotype and genotype in a litter of Jack Russell Terriers with autosomal recessive congenital ichthyosis (ARCI), and (2) the defective skin barrier and determine if a topical ceramide can modulate the barrier. ANIMALS A healthy dam and litter of Jack Russell Terrier puppies (healthy male, affected male and female), one affected adult Jack Russell Terrier and one unrelated healthy Jack Russell Terrier. MATERIALS AND

METHODS:

A severe cornification defect was identified via examination of affected puppies. As the phenotype worsened, the affected puppies received a topical application of ω-0-acylceramide for 10 days. Before humane euthanasia, the skin barrier was evaluated via transepidermal water loss (TEWL), corneometry and pH in affected dogs. Genomic testing was performed, and skin samples were analysed by light and electron microscopy.

RESULTS:

Affected puppies were homozygous for the 1980 bp LINE-1 insertion in the TGM1 (transglutaminase 1) gene; the unaffected littermate and the dam were heterozygous carriers. ARCI puppies were underweight and had a severe hyperkeratotic phenotype that impaired mobility. TEWL was markedly higher in affected dogs. The cutaneous pH of affected puppies was higher than the normal littermate. Treatment of the skin with ω-0-acylceramide normalised the pH to match the littermate and decreased TEWL. Electron microscopy revealed marked attenuation of the cornified envelope. CONCLUSIONS AND CLINICAL RELEVANCE Dogs with TGM1-deficient ARCI have an impaired skin barrier. Topical therapy can partially repair the barrier defect.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article